SUCH A POWERFUL INGREDIENT

Supporting your cartilage is the key to long-term joint health.* More and more health-conscious, active individuals feeling occasional aches and pains are looking for a natural alternative to reach for – something to use proactively that will not only support joint flexibility quickly, but also ensure their future joint health.

WHAT IS
INSIDE NEM® ?

HOW IT WORKS?

  • PAIN
    REDUCTION
Even minor day-to-day injuries can cause pain and discomfort in and around our joints. A new study in a healthy population shows that NEM® may help provide a rapid reduction of exercise-induced joint aches and pains in 7-10 days.

This fast-acting support has also been demonstrated in 5 other clinical trials previously published on NEM®.

A 2017 randomized, double-blind, placebo-controlled trial (RCT) in a healthy population revealed NEM’s ability toreduce joint paim associated with exercise in healthy individuals in just 8 days. *1 NEM® is the first dietary ingredientthat has been shown to reduce exercise-induced pain in truly healthy subjects. It has also demonstrated significant reduction in pain in 5 other published clinical trials.*2-5

GREATER DECREASE WITH NEM®

*These ststements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disesse. 
The material included in this emall is intended for informational and educational purposes only and does not supersede the requirement for submitting claims to the FDA.
  • STIFFNESS
    REDUCTION
Joint stiffness is often a result of inflammation. New research shows NEM® and strawberry extract in OVOCAL® have the ability to reduce inflammation and joint stiffness in a quick 4 days.*
NEM® May Provide:
  • CARTILAGE
    PROTECTION
OVOCAL® takes joint support to a new level. As latest clinical studies suggest that NEM® in OVOCAL® can dramatically reduce cartilage degradation associated with daily wear and tear.

WHY TEST THE CARTILAGE
BIOMARKER CTX-II?

 

CTX-II (carboxy-terminal telopeptide of Collagen Type II) is a biomarker of cartilage degradation that can be measured in both urine and serum and is used to assess the level of cartilage turnover. CTX-II levels are elevated in individuals where there is increased cartilage turnover, such as growing adolescents, endurance athletes, post-menopausal women and overweight individuals. The more strenuous and higher impact (jarring) the exercise, the higher the CTX-II output.

NEM® REDUCES CTX-II

Net treatment effect at Week 1 was-17.2%
Net treatment effect at Week 2 was-9.9%

Clinical result

OVOCAL®

110 E Southern Ave
Mesa AZ 85210
email : ovocal.info@gmail.com

Explore

Contact us

© All rights reserved